A forum for researchers, students and applicants in the field of cyclodextrin technology
Cyclo Therapeutics, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C
ADAMA MAKHTESHIM LTD. (Israel) filed a PCT patent application (WO2020084572) that was recently published. The invention relates to preparation and use
Cyclo Therapeutics reported the publication of an international patent application for the treatment of Alzheimer’s disease with HPBCD.
Dental Tribune, the European blog of dentists published a post on the possible application of cyclodextrins as a mouth rinse
Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC)
Due to the reported high ability of virulence of COVID_19 in recent months, several studies have been conducted to discover
Hops are the flowers (also called seed cones or strobiles) of the hop plant Humulus lupulus. They are used primarily
Curcumin/Hydroxypropyl-beta-Cyclodextrin (HP-β-CD) and Curcumin/Hydroxypropyl-gamma-Cyclodextrin (HP-γ-CD) inclusion complex nanofibrous webs were produced using electrospinning technique for the purpose of orally fast-dissolving
Roquette has recently identified that its KLEPTOSE® hydroxypropyl beta-cyclodextrins (HPβCD) product, a functional excipient and a specialty active pharmaceutical ingredient (API),
Cyclo Therapeutics, Inc. a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC)
